Proteomic Analysis of NULISA™ plasma analytes and Associations with Neurocognitive measures and Incident Dementia in older adults

Abstract

Background: Neurodegenerative diseases, including Alzheimer's disease (AD), are characterized by progressive cognitive decline, with plasma biomarkers potentially playing a key role in early detection and risk assessment.